Skip to main content
Erschienen in: Gynecological Surgery 3/2016

12.03.2016 | Short Communication

Expulsion of correctly placed Essure® device during endometrial sampling

verfasst von: Mamta Pathak, Robert James Johnson

Erschienen in: Gynecological Surgery | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Excerpt

Expulsion of an Essure® device is a known complication of the procedure and possibly occurs due to proximal migration when more than 50 % of the coil if left in the uterine cavity. In the phase II, the expulsion rate was 0.5 % and, in pivotal trials, the expulsion rate was 2.9 %. The women were instructed not to rely on the Essure® system for birth control even when the hysterosalpingogram (HSG) may have demonstrated occlusion of the fallopian tubes. It is possible that the expulsion of device occurs in women where inadequate fibrosis occurs to anchor the device securely. In the clinical trials for Essure®, delayed fibrosis was noted in 3 % women who needed second HSG in 6 months before tubal occlusion was confirmed. It is therefore likely that there is inadequate anchoring of the device in some women making the device prone to displacement and expulsion [13]. Patulous or wider diameter fallopian tubes could also be predisposed to expulsion. …
Literatur
1.
Zurück zum Zitat Cooper JM, Carignan CS, Cher D, Kerin JF (2003) Selective Tubal Occlusion Procedure 2000 Investigators Group. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 102:59–67PubMed Cooper JM, Carignan CS, Cher D, Kerin JF (2003) Selective Tubal Occlusion Procedure 2000 Investigators Group. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 102:59–67PubMed
2.
Zurück zum Zitat Kerin JF, Cooper JM, Price T, et al. (2003) Hysteroscopic sterilization using a micro-insert device: results of a multicenter phase II study. Hum Reprod 18:1223–1230CrossRefPubMed Kerin JF, Cooper JM, Price T, et al. (2003) Hysteroscopic sterilization using a micro-insert device: results of a multicenter phase II study. Hum Reprod 18:1223–1230CrossRefPubMed
3.
Zurück zum Zitat Essure® Permanent Birth Control System [instructions for use] Mountain View, CA: Conceptus, Inc.; 2002.) Essure® Permanent Birth Control System [instructions for use] Mountain View, CA: Conceptus, Inc.; 2002.)
4.
Zurück zum Zitat B. Povedano, JE Arijona, JA Monserrat, J Lorente, C Castelo-Branco. Complications of Essure hysteroscopic sterilisation: report on 4306 procedures performed in a single centre.BJOG June 2012;(7):795–799 B. Povedano, JE Arijona, JA Monserrat, J Lorente, C Castelo-Branco. Complications of Essure hysteroscopic sterilisation: report on 4306 procedures performed in a single centre.BJOG June 2012;(7):795–799
5.
Zurück zum Zitat Garcia AL1, Lewis RM, Sloan AL. Essure insert expulsion after 3-month hysterosalpingogram confirmation of bilateral tubal occlusion and bilateral correct placement: case report. J Minim Invasive Gynecol. 2013 Jan-Feb. 20(1):107–111 Garcia AL1, Lewis RM, Sloan AL. Essure insert expulsion after 3-month hysterosalpingogram confirmation of bilateral tubal occlusion and bilateral correct placement: case report. J Minim Invasive Gynecol. 2013 Jan-Feb. 20(1):107–111
Metadaten
Titel
Expulsion of correctly placed Essure® device during endometrial sampling
verfasst von
Mamta Pathak
Robert James Johnson
Publikationsdatum
12.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Gynecological Surgery / Ausgabe 3/2016
Print ISSN: 1613-2076
Elektronische ISSN: 1613-2084
DOI
https://doi.org/10.1007/s10397-016-0938-4

Weitere Artikel der Ausgabe 3/2016

Gynecological Surgery 3/2016 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.